Similar articles

• Zongertinib in Previously Treated HER2-Mutant Non-Small-Cell Lung Cancer.

  Heymach JV, Ruiter G, Ahn MJ, Girard N, Smit EF, Planchard D, Wu YL, Cho BC, Yamamoto N, Sabari JK, Zhao Y, Tu HY, Yoh K, Nadal E, Sadrolhefazi B, Rohrbacher M, von Wangenheim U, Eigenbrod-Giese S, Zugazagoitia J; Beamion LUNG-1 Investigators. Heymach JV, et al. N Engl J Med. 2025 Jun 19;392(23):2321-2333. doi: 10.1056/NEJMoa2503704. Epub 2025 Apr 28. N Engl J Med. 2025. PMID: 40293180 Clinical Trial.
• Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.

  Wilding B, Woelflingseder L, Baum A, Chylinski K, Vainorius G, Gibson N, Waizenegger IC, Gerlach D, Augsten M, Spreitzer F, Shirai Y, Ikegami M, Tilandyová S, Scharn D, Pearson MA, Popow J, Obenauf AC, Yamamoto N, Kondo S, Opdam FL, Bruining A, Kohsaka S, Kraut N, Heymach JV, Solca F, Neumüller RA. Wilding B, et al. Cancer Discov. 2025 Jan 13;15(1):119-138. doi: 10.1158/2159-8290.CD-24-0306. Cancer Discov. 2025. PMID: 39248702 Free PMC article.
• Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report.

  Illini O, Lang-Stöberl AS, Fabikan H, Weinlinger C, Valipour A, Hochmair MJ. Illini O, et al. Cancer Treat Res Commun. 2024;42:100875. doi: 10.1016/j.ctarc.2025.100875. Epub 2025 Feb 1. Cancer Treat Res Commun. 2024. PMID: 39904276
• PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review.

  Brody R, Zhang Y, Ballas M, Siddiqui MK, Gupta P, Barker C, Midha A, Walker J. Brody R, et al. Lung Cancer. 2017 Oct;112:200-215. doi: 10.1016/j.lungcan.2017.08.005. Epub 2017 Aug 10. Lung Cancer. 2017. PMID: 29191596
• Efficacy of targeted therapy in patients with HER2-positive non-small cell lung cancer: A systematic review and meta-analysis.

  Wu HX, Zhuo KQ, Wang K. Wu HX, et al. Br J Clin Pharmacol. 2022 May;88(5):2019-2034. doi: 10.1111/bcp.15155. Epub 2021 Dec 21. Br J Clin Pharmacol. 2022. PMID: 34820879 Free PMC article.